IP Library › Granted Patent US 12,251,433
Granted Patent B2
US 12,251,433 · App. 17/316,219 · Granted Mar 18, 2025

Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVS) for delivery to the GI-tract

Inventors: Regis Gabriel Stentz (Norwich, GB); Simon Richard Carding (Norwich, GB)
Assignees: QUADRAM INSTITUTE BIOSCIENCE; UEA ENTERPRISES LIMITED
A61K39/0216A61K35/74A61K39/0275A61P31/04C12N1/20C12N9/2488C12N15/52C12N15/74C12P21/02A61K38/00A61K2039/541A61K2039/6068C07K2319/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,251,433
App. No.
17/316,219
Granted
Mar 18, 2025
Kind
B2
Abstract

This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.

Claims (17)

1. A recombinant gram negative commensal gut bacterium from the Bacteroides genus comprising an expression system for expression of a heterologous peptide or protein, wherein said heterologous peptide or protein is contained in an outer membrane vesicle (OMV), characterised in that the heterologous peptide or protein is fused to the N-terminal signal peptide of the OMV-secreted protein Bt OmpA.

2. A recombinant gram negative commensal gut bacterium as claimed in claim 1 wherein the heterologous peptide or protein is a therapeutic peptide, a therapeutic protein or an antigen.

3. A recombinant gram negative commensal gut bacterium as claimed in claim 1 wherein the expression system is a mannan-controlled inducible gene expression system.

4. A recombinant gram negative commensal gut bacterium as claimed in claim 3 wherein the inducible gene expression system comprises:

a mannan-inducible promoter region of an alpha-1,2-mannosidase gene;

at least one ribosomal binding site;

a multiple cloning site; and

a transcriptional terminator.

5. A method for preparing an outer membrane vesicle (OMV) containing a heterologous peptide or protein within the OMV, comprising generating a recombinant gram negative commensal gut bacterium from the Bacteroides genus that expresses a heterologous peptide or protein fused to the N-terminal signal peptide of the OMV-secreted protein Bt OmpA, BtMinpp or BtCepA, cultivating the bacterium under conditions that result in the expression of said heterologous peptide or protein and the production of OMV, and isolating OMV thereby containing said heterologous peptide or protein.

6. A method as claimed in claim 5 wherein expression of the heterologous peptide or protein is mannan-inducible.

7. A method as claimed in claim 6 wherein induction of the expression of the heterologous peptide or protein is delayed until OMV production.

8. A method as claimed in claim 7 wherein induction of the expression of the heterologous peptide or protein is tuned using varying concentrations of mannan.

9. A recombinant gram negative commensal gut bacterium as claimed in claim 1 wherein the recombinant gram negative commensal gut bacterium is Bacteroides thetaiotaomicron (Bt).

10. A recombinant gram negative commensal gut bacterium from the Bacteroides genus comprising an expression system for expression of a heterologous peptide or protein within an outer membrane vesicle (OMV), characterised in that the heterologous peptide or protein is fused to the N-terminal signal peptide of an OMV secreted protein.

11. A recombinant gram negative commensal gut bacterium as claimed in claim 10 wherein the heterologous peptide or protein is fused to the N-terminal signal peptide of the OMV-secreted protein Bt OmpA.

12. A recombinant gram negative commensal gut bacterium from the Bacteroides genus comprising an expression system for expression of a heterologous peptide or protein, wherein said heterologous peptide or protein is contained in an outer membrane vesicle (OMV), characterised in that the heterologous peptide or protein is fused to the N-terminal signal peptide of the OMV-secreted protein BtMinpp.

13. A recombinant gram negative commensal gut bacterium from the Bacteroides genus comprising an expression system for expression of a heterologous peptide or protein, wherein said heterologous peptide or protein is contained in an outer membrane vesicle (OMV), characterised in that the heterologous peptide or protein is fused to the N-terminal signal peptide of the OMV-secreted protein BtCepA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2021
From: STENTZ, REGIS GABRIEL; CARDING, SIMON RICHARD
To: QUADRAM INSTITUTE BIOSCIENCE; UEA ENTERPRISES LIMITED
Reel/Frame 056190/0202 →
Priority Claims (1)
GB 1607510 · Apr 29, 2016 · national
Continuity (2)
Division 16086906
Related Publication 20210268094A1 · Sep 2, 2021
References Cited (3)
US 11000581B2 · Stentz · 2021 [cited by examiner]
US 11766461B2 · Sonnenburg · 2023 [cited by examiner]
US 20170145061A1 · Lu · 2017 [cited by examiner]